C4 Therapeutics, Inc. (CCCC)

NASDAQ

$3.10

$+0.19

(+6.57%)

Regular Market

C4 Therapeutics, Inc. (CCCC) Live Price Chart

Last updated: ⁦2026-10-20 15:58:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

C4 Therapeutics, Inc. (CCCC) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $3.10, with a market capitalization of $340.16M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.69 to $5.17. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$340.16M
Open	$2.86
Day's High	$51.21
Day's Low	$1.06
Previous Close	$2.89
Volume	2.16M
Average Volume	2.34M
P/E Ratio	--
52-Week High	$5.17
52-Week Low	$1.69
Dividend Yield	--
Earnings Date	--

C4 Therapeutics, Inc. (CCCC) Stock Price Today

C4 Therapeutics, Inc. (CCCC) is currently trading at $3.10 as of 2026-10-20 15:42:54, up 7.09% ($0.21) from the previous close of $2.89

During today's regular trading session, CCCC has traded between $1.06 and $51.21, with a trading volume of 2.16M shares. The current price is near the lower end of today's range.

C4 Therapeutics, Inc. (CCCC) 7-Day Stock Price Change

Over the past seven days, C4 Therapeutics, Inc. (CCCC) moved from $3.16 to $3.10, representing a decline of 2.06% ($0.06).

The stock traded between $2.59 and $3.30 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.

The average daily volume was 2.81 million shares, up versus the previous seven-day period, indicating higher trading activity.

CCCC 52-Week Price Position

Position in Range: 40.4%

52W Low$1.69

52W High$5.17

CCCC is currently trading at $3.10, placing it 40.4% of the way from its 52-week low of $1.69 to its 52-week high of $5.17. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is C4 Therapeutics, Inc. (CCCC)?

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

C4 Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	104
Exchange	NASDAQ
Company Website	https://www.c4therapeutics.com

How to Buy C4 Therapeutics, Inc. (CCCC) Stock on MEXC

Eligible investors can buy real shares of C4 Therapeutics, Inc. (CCCC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CCCC and Place Your Order

Open the RealStocks trading page and search for CCCC. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is C4 Therapeutics, Inc. (CCCC) stock price today?

C4 Therapeutics, Inc. (CCCC) is currently trading at $ 3.10, up 7.09% ($0.21) from the previous close of $ 2.89. Intraday prices update in real time during regular trading hours.

2.Is CCCC stock going up or down today?

As of 2026-10-20 15:42:54, CCCC is trading at $ 3.10, up 7.09% ($0.21) from its previous close of $ 2.89. The stock has traded between $ 1.06 and $ 51.21 during today’s regular session. Past price movements do not guarantee future results.

3.What is CCCC pre-market price?

As of 2026-10-20 15:42:54, CCCC is trading at $ 2.94 in pre-market trading, up 1.56% ($0.04) from the previous close of $ 2.89. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CCCC after-hours price?

As of 2026-10-20 15:42:54, CCCC is trading at $ 2.90 in after-hours trading, up 0.24% ($0.01) from the regular-session close of $ 2.89. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CCCC stock trading now?

CCCC trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CCCC sit relative to its 52-week high and low?

Over the past 52 weeks, CCCC has traded between a low of $ 1.69 and a high of $ 5.17. At $ 3.10, the stock is positioned 40.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is C4 Therapeutics, Inc. in?

C4 Therapeutics, Inc. (CCCC) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is C4 Therapeutics, Inc.'s market capitalization and where is it listed?

C4 Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 340.16M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CCCC valued in terms of P/E ratio and EPS?

CCCC trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.82. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does C4 Therapeutics, Inc. pay a dividend?

C4 Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.